Viruses 2010, 2(2), 468-502; doi:10.3390/v2020468

PEGylated Adenoviruses: From Mice to Monkeys

1email and 1,2,* email
Received: 20 November 2009; in revised form: 20 January 2010 / Accepted: 25 January 2010 / Published: 1 February 2010
(This article belongs to the Special Issue Novel Viral Vector Systems for Gene Therapy)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Covalent modification with polyethylene glycol (PEG), a non-toxic polymer used in food, cosmetic and pharmaceutical preparations for over 60 years, can profoundly influence the pharmacokinetic, pharmacologic and toxciologic profile of protein and peptide-based therapeutics. This review summarizes the history of PEGylation and PEG chemistry and highlights the value of this technology in the context of the design and development of recombinant viruses for gene transfer, vaccination and diagnostic purposes. Specific emphasis is placed on the application of this technology to the adenovirus, the most potent viral vector with the most highly characterized toxicity profile to date, in several animal models.
Keywords: adenovirus; gene therapy; vaccine; toxicity; PEGylation; targeting; pharmacokinetics; immune response; tolerance; non-viral vectors
PDF Full-text Download PDF Full-Text [658 KB, uploaded 1 February 2010 16:47 CET]

Export to BibTeX |

MDPI and ACS Style

Wonganan, P.; Croyle, M.A. PEGylated Adenoviruses: From Mice to Monkeys. Viruses 2010, 2, 468-502.

AMA Style

Wonganan P, Croyle MA. PEGylated Adenoviruses: From Mice to Monkeys. Viruses. 2010; 2(2):468-502.

Chicago/Turabian Style

Wonganan, Piyanuch; Croyle, Maria A. 2010. "PEGylated Adenoviruses: From Mice to Monkeys." Viruses 2, no. 2: 468-502.

Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert